BioTechX, America's premier biotech congress on the 17th and 18th September in Philadelphia US Seeking Biodata, Pharma AI, and Genomics experts, email anna.abiola@terrapinn.com. Register for free here: https://hubs.li/Q02wx3cb0
BioSpace
Internet News
West Des Moines, Iowa 112,896 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus. https://hubs.li/Q02GDm_P0 #pharma #lupus #biospace
Artiva Targets $116M in Latest IPO Push
biospace.com
-
Lexeo Therapeutics' investigational gene therapy reduces left ventricular volume and wall thickness in patients with Friedreich’s ataxia, according to a small study. https://hubs.li/Q02GDvnQ0 #pharma #biospace
Lexeo’s Gene Therapy Shows Early Promise for Friedreich’s Ataxia Cardiomyopathy
biospace.com
-
Opinion: Congress must reauthorize FDA program for pediatric rare diseases Why Matthew Winton advocated on Capitol Hill this month for the renewal of the FDA’s Priority Review Voucher program: https://hubs.li/Q02Gy9BK0 #regulatory #pharma #biospace
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases
biospace.com
-
After a busy first half of 2024, several companies are expecting key data readouts in the neuropsychiatric and neurodegenerative disease spaces during the next six months. https://hubs.li/Q02Gyd430 #pharma #biospace
5 Neuro Data Readouts to Watch in the Second Half of 2024
biospace.com
-
Halia Therapeutics, Inc., NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression. https://hubs.li/Q02Gy9df0 #pharma #Parkinsons #biospace
Breaking the Cycle of Inflammation in Parkinson’s Disease
biospace.com
-
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. https://hubs.li/Q02Gyb2l0 #pharma #biospace
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
biospace.com
-
Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk's Ozempic is associated with lower risks of dementia, cognitive deficit and nicotine misuse. https://hubs.li/Q02Gyd3x0 #pharma #biospace
Ozempic Tied to Lower Risk of Dementia, Nicotine Misuse: Study
-
Following a disappointing IPO and the loss of Moderna's gene editing contract, Metagenomi's Chief Scientific Officer Luis Borges is departing the biotech. https://hubs.li/Q02Gy86J0 #pharma #biospace
Metagenomi CSO Steps Down Shortly After IPO, Moderna Exit
biospace.com
-
The FDA has rejected Novo Nordisk's once-weekly insulin icodec. In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA's decisions in 2024. https://hubs.li/Q02Grm2J0 #pharma #biospace
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected | BioSpace
biospace.com